NO20043313L - Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner - Google Patents
Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjonerInfo
- Publication number
- NO20043313L NO20043313L NO20043313A NO20043313A NO20043313L NO 20043313 L NO20043313 L NO 20043313L NO 20043313 A NO20043313 A NO 20043313A NO 20043313 A NO20043313 A NO 20043313A NO 20043313 L NO20043313 L NO 20043313L
- Authority
- NO
- Norway
- Prior art keywords
- cox
- inhibitors
- treatment
- combination
- antiviral agents
- Prior art date
Links
- 208000009608 Papillomavirus Infections Diseases 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34755002P | 2002-01-10 | 2002-01-10 | |
PCT/US2003/000016 WO2003059347A1 (en) | 2002-01-10 | 2003-01-10 | Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20043313L true NO20043313L (no) | 2004-10-08 |
Family
ID=23364195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043313A NO20043313L (no) | 2002-01-10 | 2004-11-04 | Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner |
Country Status (16)
Country | Link |
---|---|
US (1) | US20030211163A1 (es) |
EP (1) | EP1463500A1 (es) |
JP (1) | JP2005519061A (es) |
KR (1) | KR20040072720A (es) |
CN (1) | CN1697654A (es) |
AU (1) | AU2003201811A1 (es) |
BR (1) | BR0306820A (es) |
CA (1) | CA2472459A1 (es) |
CO (1) | CO5590913A2 (es) |
IL (1) | IL162726A0 (es) |
MX (1) | MXPA04006572A (es) |
NO (1) | NO20043313L (es) |
PL (1) | PL371252A1 (es) |
RU (1) | RU2004121147A (es) |
WO (1) | WO2003059347A1 (es) |
ZA (1) | ZA200404881B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7740868B2 (en) | 1999-08-25 | 2010-06-22 | Allergan, Inc. | Activatable clostridial toxins |
EP1700918B1 (en) | 1999-08-25 | 2014-01-15 | Allergan, Inc. | Activatable recombinant neurotoxins |
US20040152752A1 (en) * | 2002-05-30 | 2004-08-05 | Chong Kong Teck | Treatment for human papillomavirus |
EP1572186A2 (en) * | 2002-12-19 | 2005-09-14 | Pharmacia Corporation | Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents |
WO2005055932A2 (en) | 2003-12-02 | 2005-06-23 | 3M Innovative Properties Company | Therapeutic combinations and methods including irm compounds |
US20100009928A1 (en) | 2004-03-29 | 2010-01-14 | Cheng Jin Q | Compositions including triciribine and taxanes and methods of use thereof |
US8080560B2 (en) | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
PE20061303A1 (es) * | 2005-03-30 | 2006-12-07 | Astion Dev As | Composicion farmaceutica que comprende oxaprozina |
CA2609303A1 (en) * | 2005-05-18 | 2006-11-23 | Alt Solutions, Inc. | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
KR100644968B1 (ko) * | 2005-10-28 | 2006-11-14 | 한국과학기술연구원 | 생체적합성 실리콘 나노입자의 제조 방법 |
JP2010504359A (ja) | 2006-09-20 | 2010-02-12 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 局部麻酔および/または疼痛緩和のための、揮発性麻酔剤を送達するための方法 |
ITRM20080027A1 (it) * | 2008-01-18 | 2009-07-19 | Maria Balestrieri | Uso di aciclovir per il trattamento delle condilomatosi. |
CN102014961B (zh) | 2008-01-22 | 2017-10-13 | 得克萨斯大学体系董事会 | 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物 |
BRPI0910891A2 (pt) * | 2008-04-15 | 2015-09-29 | Mallinckrodt Inc | composições contendo compostos antivirais e métodos de usar os mesmo |
IL192335A0 (en) * | 2008-06-19 | 2011-08-01 | Avivi Easy Life Ltd | Antiviral compounds |
US20110218241A1 (en) * | 2010-03-06 | 2011-09-08 | Cacao Bio-Technologies, Llc | Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts |
JP2012020991A (ja) * | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
US10632087B2 (en) | 2012-02-06 | 2020-04-28 | Innovative Med Concepts, LLC. | Famciclovir and meloxicam combination therapy for functional somatic syndromes |
TWI646091B (zh) * | 2012-12-28 | 2019-01-01 | 日商衛斯克慧特股份有限公司 | 鹽類及晶形 |
WO2016036588A1 (en) * | 2014-09-03 | 2016-03-10 | Merck Sharp & Dohme Corp. | Pharmaceutical suspensions containing etoricoxib |
CN105906496A (zh) * | 2016-05-16 | 2016-08-31 | 苏州毕诺佳医药技术有限公司 | 一种阿昔洛韦的药物组合物及其医药用途 |
CN117860740A (zh) * | 2020-12-28 | 2024-04-12 | 中以海德人工智能药物研发股份有限公司 | 一种用于治疗或预防病毒性肝炎的药物组合物及其应用 |
WO2022245950A1 (en) * | 2021-05-19 | 2022-11-24 | University Of Miami | Treatment of infections in and around the eye |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
CN1098256C (zh) * | 1996-04-12 | 2003-01-08 | G·D·瑟尔公司 | 作为cox-2抑制剂前药的取代的苯磺酰胺衍生物 |
GB9615867D0 (en) * | 1996-07-03 | 1996-09-11 | Merck & Co Inc | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
WO1999030721A1 (en) * | 1997-12-17 | 1999-06-24 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
KR20020024587A (ko) * | 1999-05-14 | 2002-03-30 | 린다 에스. 스티븐슨 | 염증 매개성 감염에 대한 항염증 치료 |
US20030004142A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
WO2002085327A2 (en) * | 2001-04-18 | 2002-10-31 | Oraltech Pharmaceuticals, Inc. | Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract |
-
2003
- 2003-01-10 CA CA002472459A patent/CA2472459A1/en not_active Abandoned
- 2003-01-10 PL PL03371252A patent/PL371252A1/xx not_active Application Discontinuation
- 2003-01-10 RU RU2004121147/14A patent/RU2004121147A/ru not_active Application Discontinuation
- 2003-01-10 WO PCT/US2003/000016 patent/WO2003059347A1/en not_active Application Discontinuation
- 2003-01-10 MX MXPA04006572A patent/MXPA04006572A/es not_active Application Discontinuation
- 2003-01-10 US US10/339,906 patent/US20030211163A1/en not_active Abandoned
- 2003-01-10 EP EP03700670A patent/EP1463500A1/en not_active Withdrawn
- 2003-01-10 IL IL16272603A patent/IL162726A0/xx unknown
- 2003-01-10 JP JP2003559509A patent/JP2005519061A/ja active Pending
- 2003-01-10 KR KR10-2004-7010785A patent/KR20040072720A/ko not_active Application Discontinuation
- 2003-01-10 CN CNA038057212A patent/CN1697654A/zh active Pending
- 2003-01-10 AU AU2003201811A patent/AU2003201811A1/en not_active Abandoned
- 2003-01-10 BR BR0306820-0A patent/BR0306820A/pt not_active IP Right Cessation
-
2004
- 2004-06-21 ZA ZA200404881A patent/ZA200404881B/en unknown
- 2004-07-08 CO CO04064572A patent/CO5590913A2/es not_active Application Discontinuation
- 2004-11-04 NO NO20043313A patent/NO20043313L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2004121147A (ru) | 2005-04-10 |
KR20040072720A (ko) | 2004-08-18 |
IL162726A0 (en) | 2005-11-20 |
PL371252A1 (en) | 2005-06-13 |
US20030211163A1 (en) | 2003-11-13 |
CO5590913A2 (es) | 2005-12-30 |
JP2005519061A (ja) | 2005-06-30 |
ZA200404881B (en) | 2005-08-31 |
MXPA04006572A (es) | 2005-11-04 |
BR0306820A (pt) | 2004-12-07 |
CN1697654A (zh) | 2005-11-16 |
CA2472459A1 (en) | 2003-07-24 |
AU2003201811A1 (en) | 2003-07-30 |
WO2003059347A1 (en) | 2003-07-24 |
EP1463500A1 (en) | 2004-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043313L (no) | Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner | |
DK1894564T3 (da) | Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation | |
EE05516B1 (et) | Indasoolid bensotiasoolid ja bensoisotiasoolid nende valmistamine ning kasutamine | |
EE05507B1 (et) | Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks | |
CY2013043I1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
CY2014031I1 (el) | Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae | |
DK1554518T3 (da) | Gevindskåret rör med overfladebehandling | |
NO20053782D0 (no) | Behandling av kreft med 2-deoksyglukose | |
PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
FI20021144A (fi) | Menetelmä suuntaajasiltojen yhteydessä | |
EP1765330A4 (en) | PYRANOINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DISEASE OR INFECTION CAUSED BY HEPATITIS C VIRUS | |
DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
FR2864552B1 (fr) | Traitement de surface par hydroxysulfate | |
EE200300473A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
EE200300474A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
NO20041024D0 (no) | Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene | |
FI20010557A0 (fi) | Menetelmä vaihtosuuntaajan yhteydessä | |
DE60326190D1 (de) | des Körpers | |
PL377427A1 (pl) | Sposoby i kompozycje do leczenia infekcji wirusem opryszczki z zastosowaniem inhibitorów selektywnych względem cyklooksygenazy-2 lub inhibitorów cyklooksygenazy-2 w połączeniu ze środkami przeciwwirusowymi | |
DE602004021477D1 (de) | Kondensierte heterocyclen und deren verwendungen | |
DK1545553T3 (da) | Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter | |
DK1565064T3 (da) | Coatingindretning med integreret rengöringsindretning | |
DK1496918T3 (da) | Anvendelse af natriummetaarsenit til behandling af tumorer | |
DK1461042T3 (da) | Anvendelse af desoxypeganin til behandling af klinisk depression | |
NO20025303L (no) | Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen avtumorer assosiert med höye nivåer av glutation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |